Bluefire's Arkenol Technology has demonstrated a total lack of success in generating any financial investment sufficient to move it beyond previous pilot-scale demonstrations.
Since several competing technologies have been financed, built, and are now operating as commercial scale plants in the US, it would seem to me that classification of Bluefire's Arkenol technology as a failure is appropriate.
Free markets have winners and losers. Those that are never able to get in the race, are losers.
In case you missed the math in my earlier post -
Bluefire has already issued over 90M shares @ .0014 or lower and already has outstanding convertible debt that will likely create over 380M more shares at substantial discount to current market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.